BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9065925)

  • 1. Benign and hyperplastic endometrial changes associated with tamoxifen use.
    Barakat RR
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):35-7. PubMed ID: 9065925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
    Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
    J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen effects on endometrium.
    Colacurci N; De Seta L; De Franciscis P; Mele D; Fortunato N; Cassese S
    Panminerva Med; 2000 Mar; 42(1):45-7. PubMed ID: 11019604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies.
    Jeon J; Kim SE; Lee DY; Choi D
    Breast Cancer Res Treat; 2020 Jan; 179(1):125-130. PubMed ID: 31541382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
    Archer DF
    Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.
    Powles TJ; Bourne T; Athanasiou S; Chang J; Gruböck K; Ashley S; Oakes L; Tidy A; Davey J; Viggers J; Humphries S; Collins W
    Br J Cancer; 1998 Jul; 78(2):272-5. PubMed ID: 9683306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial changes with chronic tamoxifen use.
    Loret de Mola JR
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of transvaginal ultrasound in diagnosing endometrial pathology in women with post-menopausal bleeding on tamoxifen.
    Weaver J; McHugo JM; Clark TJ
    Br J Radiol; 2005 May; 78(929):394-7. PubMed ID: 15845930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrasound endometrium follow-up during tamoxifen treatment: Really not reliable or useful after all?].
    Burkart C; Wight E; Pók J; Kernen B; Traber M; Haller U; Bajka M
    Ultraschall Med; 2001 Jun; 22(3):136-42. PubMed ID: 11484445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen and the endometrium.
    Barakat RR
    Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of endometrial pathologies collected by hysteroscopy and hysterectomy in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Azaria R; Bernheim J; Tepper R; Sharony R; Beyth Y
    Eur J Gynaecol Oncol; 2000; 21(4):418-22. PubMed ID: 11055500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
    Cecchini S; Ciatto S; Bonardi R; Mazzotta A; Grazzini G; Pacini P; Muraca MG
    Gynecol Oncol; 1996 Mar; 60(3):409-11. PubMed ID: 8774648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of tamoxifen on the uterus.
    Ismail SM
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):27-31. PubMed ID: 8777254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for endometrial cancer in women receiving tamoxifen.
    Suh-Burgmann EJ; Goodman A
    Ann Intern Med; 1999 Jul; 131(2):127-35. PubMed ID: 10419429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen-induced hyperplasia of the endometrium.
    Neis KJ; Brandner P; Schlenker M
    Contrib Gynecol Obstet; 2000; 20():60-8. PubMed ID: 11791286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tamoxifen on the endometrium.
    Uziely B; Lewin A; Brufman G; Dorembus D; Mor-Yosef S
    Breast Cancer Res Treat; 1993; 26(1):101-5. PubMed ID: 8400318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonographic assessment of the endometrium in osteopenic postmenopausal women treated with idoxifene.
    Fleischer AC; Wheeler JE; Yeh IT; Kravitz B; Jensen C; MacDonald B
    J Ultrasound Med; 1999 Jul; 18(7):503-12. PubMed ID: 10400054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.